Cargando…

Efficacy of rituximab in pediatric pemphigus: A literature review

Detalles Bibliográficos
Autores principales:	Patel, Meera H., Brumfiel, Caitlin M., Bohrer, Nicholas, Marsch, Amanda F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605268/ https://www.ncbi.nlm.nih.gov/pubmed/34825231 http://dx.doi.org/10.1016/j.jdin.2021.10.002

Ejemplares similares

Successful Treatment of Recalcitrant Pediatric Pemphigus Vulgaris With Rituximab
por: Santiago-Vázquez, Marely, et al.
Publicado: (2022)

Efficacy of Repeated Courses of Rituximab as Treatment for Pemphigus Vulgaris
por: BAUM, Sharon, et al.
Publicado: (2020)

The positive impact of rituximab on the quality of life and mental health in patients with pemphigus
por: Rashid, Hanan, et al.
Publicado: (2022)

Rituximab in the Treatment of Pemphigus Vulgaris
por: Zakka, Labib R., et al.
Publicado: (2012)

Assessing the Safety and Efficacy of Trifarotene in the Treatment of Acne Vulgaris
por: Brumfiel, Caitlin M, et al.
Publicado: (2021)

Rituximab Therapy for Treatment of Pemphigus in Southeast Asians
por: Kanokrungsee, Silada, et al.
Publicado: (2021)

Rituximab therapy improves recalcitrant Pemphigus vulgaris
por: Noormohammadpour, Pedram, et al.
Publicado: (2015)

Rituximab in Pemphigus: Road Covered and Challenges Ahead
por: Vinay, Keshavamurthy, et al.
Publicado: (2018)

Cerebral toxoplasmosis after rituximab for pemphigus vulgaris
por: Lee, Erica B., et al.
Publicado: (2019)

Rituximab therapy in a case of pemphigus vulgaris triggering herpes simplex infection at varied sites
por: Chotaliya, Kiran K., et al.
Publicado: (2015)

SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris
por: Fenizia, Claudio, et al.
Publicado: (2023)

Follow-up Data of Rituximab as Adjuvant Therapy in Pemphigus
por: Khopkar, Uday S, et al.
Publicado: (2017)

Rituximab in Pemphigus Vulgaris: A Review of Monoclonal Antibody Therapy in Dermatology
por: Khandelwal, Krishna, et al.
Publicado: (2023)

AZD-1222/rituximab: Pemphigus vulgaris and pemphigus vulgaris flare-up: 2 case reports
Publicado: (2022)

Rituximab: Aggressive course of pemphigus vulgaris: case report
Publicado: (2021)

Off-label use of rituximab in dermatology: pemphigus treatment
por: Bomm, Lislaine, et al.
Publicado: (2013)

Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil
por: Biot, Stephanie Del Rio Navarrete, et al.
Publicado: (2014)

Rituximab therapy in pemphigus and other autoantibody-mediated diseases
por: Ran, Nina A., et al.
Publicado: (2017)

Pemphigus vulgaris successfully treated with ocrelizumab following rituximab allergy
por: Benesh, Gabrielle, et al.
Publicado: (2021)

Real world evidence: Patients with refractory pemphigus treated with Rituximab
por: Perifani, Vagiani, et al.
Publicado: (2021)

Role of Rituximab in the Treatment of Pemphigus Vulgaris: Patient Selection and Acceptability
por: Ciolfi, Christian, et al.
Publicado: (2022)

Thrombotic Storm Induced by Rituximab in a Patient With Pemphigus Vulgaris
por: Karan, Abhinav, et al.
Publicado: (2023)

Brain Abscess following Rituximab Infusion in a Patient with Pemphigus Vulgaris
por: Al-Harbi, Talal M., et al.
Publicado: (2015)

Pemphigus Contagiosus
Publicado: (1905)

Immune checkpoint inhibitor therapy in a liver transplant recipient with autoimmune disease and metastatic cutaneous squamous cell carcinoma
por: Brumfiel, Caitlin M., et al.
Publicado: (2021)

Toward a COVID-19 vaccine strategy for patients with pemphigus on rituximab
por: Waldman, Reid A., et al.
Publicado: (2021)

IgG N-glycosylation from Patients with Pemphigus Treated with Rituximab
por: Font, Guillaume, et al.
Publicado: (2022)

Pregnancy outcomes in women with pemphigus exposed to rituximab before or during pregnancy
por: Dehghanimahmoudabadi, Azin, et al.
Publicado: (2022)

Transition from Pemphigus Foliaceus to Pemphigus Vulgaris: Case Report with Literature Review
por: Park, Sang Gun, et al.
Publicado: (2006)

Biologic therapy-induced pemphigus
por: Hayashida, Marina Zoega, et al.
Publicado: (2017)

Clinical impact and a prognostic marker of early rituximab treatment after rituximab reimbursement in Korean pemphigus patients
por: Song, Ahreum, et al.
Publicado: (2022)

A Comparative Study to Evaluate the Efficacy and Cost of Rituximab versus Dexamethasone Cyclophosphamide Pulse in Patients of Pemphigus Vulgaris
por: Das, Sudip, et al.
Publicado: (2021)

Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid‐sparing effect
por: Chen, D.M., et al.
Publicado: (2019)

Immunocytometric Analysis of Oral Pemphigus vulgaris Patients after Treatment with Rituximab as Adjuvant
por: Fortuna, Giulio, et al.
Publicado: (2021)

Comparison of rituximab and conventional adjuvant therapy for pemphigus vulgaris: A retrospective analysis
por: Agarwal, Ashwin, et al.
Publicado: (2018)

Crusted scabies in a patient with pemphigus vulgaris after treatment with rituximab and corticosteroids
por: Ashrafzadeh, Sepideh, et al.
Publicado: (2020)

T Cells Remember SARS-CoV-2 in Rituximab-Treated Pemphigus Vulgaris
por: Croitoru, David O., et al.
Publicado: (2023)

Treatment of Pediatric Pemphigus Foliaceus
por: Carver, Caden, et al.
Publicado: (2023)

Mycobacterium tuberculosis and pemphigus vulgaris
por: Osipowicz, Katarzyna, et al.
Publicado: (2018)

A comparative analysis of tuberculosis in vitro screening in pemphigus patients selected for treatment with rituximab
por: Jałowska, Magdalena, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1dgrlf8i5ook0vldim8i6h21fu